Calithera Biosciences is a biotechnology business based in the US. Calithera Biosciences shares (CALA) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.01 – the same closing value as a week prior. Calithera Biosciences employs 8 staff and has a market cap (total outstanding shares value) of 0.00.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.01 |
|---|---|
| 52-week range | $0.00 - $0.05 |
| 50-day moving average | $0.00 |
| 200-day moving average | $0.01 |
| Wall St. target price | $5.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-66.17 |
Historical closes compared with the close of $0.005 from 2025-05-02
| 1 week (2025-04-25) | 0.005 |
|---|---|
| 1 month (2025-04-04) | 733.33% |
| 3 months (2025-02-05) | 733.33% |
| 6 months (2024-11-05) | -28.57% |
| 1 year (2024-05-02) | -75.00% |
|---|---|
| 2 years (2023-05-04) | -80.00% |
| 3 years (2022-05-04) | 5.194 |
| 5 years (2020-05-04) | 140.2 |
| Gross profit TTM | $-28,533,000 |
|---|---|
| Return on assets TTM | -56.29% |
| Return on equity TTM | -114.14% |
| Profit margin | 0% |
| Book value | $-0.40 |
| Market Capitalization | $24,362 |
TTM: trailing 12 months
We're not expecting Calithera Biosciences to pay a dividend over the next 12 months.
Calithera Biosciences's shares were split on a 1:20 basis on 14 June 2022 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Calithera Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Calithera Biosciences shares which in turn could have impacted Calithera Biosciences's share price.
Over the last 12 months, Calithera Biosciences's shares have ranged in value from as little as $0.0001 up to $0.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Calithera Biosciences's is -1.159. This would suggest that Calithera Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Calithera Biosciences has bucked the trend.
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. .
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.